/Zoetis%20sign%20at%20their%20Canadian%20By%20JHVEPhoto.jpeg)
With a market cap of $31.2 billion, Zoetis Inc. (ZTS) is the world's leading animal health company, dedicated to advancing animal care through innovative medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. With nearly 75 years of scientific expertise and a presence in over 100 countries, Zoetis empowers veterinarians, livestock producers, and pet owners by pioneering solutions to predict, prevent, detect, and treat animal illness.
The Parsippany, New Jersey-based company is slated to announce its fiscal Q2 2026 results before the market opens on Thursday, Aug. 6. Ahead of the event, analysts expect Zoetis to report an adjusted EPS of $1.85, up 5.1% from $1.76 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarterly reports while missing on another occasion.
